About ReadyCell

Developing innovative in-vitro kits for the ADME-Tox segment

We develop, implement and commercialize cell-based ready-to-use kits that provide reliable results reducing time and costs. Pharmaceutical and biotech companies can use human and material resources more efficiently, while optimizing the development cycle for new drugs.

Our R&D department works on the expansion of our product portfolio, with the aim of developing new tools that fulfill the needs of the pharmaceutical industry. By offering a diversity of R&D service, we offer our expertise, know-how, technical & human resources to develop ad-hoc solutions.

Partners

News

Meet us at BioAsia 2020 in India

Meet us at BioAsia 2020 in India

ReadyCell is happy to announce that its tean will be attending this year’s BioAsia Conference taking place from 17 – 19 February 2020 in Hyderabad, India. If you want to meet us there, contact us! BioAsia is a comprehensive framework dedicated to...

We are hiring a Business Developer

We are hiring a Business Developer

Readycell, desarrolla, implementa y comercializa kits de base celular, preparados para su uso, que aportan análisis con un alto nivel de fiabilidad, reduciendo tiempo y costes, y permitiendo que las compañías farmacéuticas y biotecnológicas que lo utilizan puedan...